Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam I Raad

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Medicine|April 9, 2016
Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal OrganismZainab Al Hamal, Mary Jordan, Ray Y Hachem, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortalityHarrys A Torres, Dimitrios P Kontoyiannis, Elizabeth A Aguilera, et al.
Cancer|July 23, 2003
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignanciesDimitrios P Kontoyiannis, Ray Hachem, Russell E Lewis, et al.
Cancer|September 21, 2004
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignanciesRay Y Hachem, Dimitrios P Kontoyiannis, Maha R Boktour, et al.
Pathogens (Basel, Switzerland)|April 3, 2021
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 InfectionAhmed O Kaseb, Yehia I Mohamed, Alexandre E Malek, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2025
Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by <i>Aspergillus terreus</i> After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer CenterRay Y Hachem, Hiba Dagher, Anne-Marie Chaftari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2005
Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer centerHarrys A Torres, Dimitrios P Kontoyiannis, Gerald P Bodey, et al.
The Journal of Infectious Diseases|March 19, 2005
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent casesDimitrios P Kontoyiannis, Michail S Lionakis, Russell E Lewis, et al.
Medicine|September 16, 2006
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer centerRoy F Chemaly, Shubhra Ghosh, Gerald P Bodey, et al.
Cancer|May 13, 2006
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusionsAmar Safdar, Gilhen H Rodriguez, Benjamin Lichtiger, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Medicine|April 9, 2016
Mycobacterium arupense in Cancer Patients: An Emerging Infection or a Commensal OrganismZainab Al Hamal, Mary Jordan, Ray Y Hachem, et al.
Clinical Lymphoma & Myeloma|April 28, 2006
Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortalityHarrys A Torres, Dimitrios P Kontoyiannis, Elizabeth A Aguilera, et al.
Cancer|July 23, 2003
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignanciesDimitrios P Kontoyiannis, Ray Hachem, Russell E Lewis, et al.
Cancer|September 21, 2004
Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignanciesRay Y Hachem, Dimitrios P Kontoyiannis, Maha R Boktour, et al.
Pathogens (Basel, Switzerland)|April 3, 2021
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 InfectionAhmed O Kaseb, Yehia I Mohamed, Alexandre E Malek, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2025
Decreased Frequency and Improved Outcomes in Invasive Aspergillosis Caused by <i>Aspergillus terreus</i> After the Introduction of Anti-Mold Azole Agents: A 30-Year Study at a Tertiary Cancer CenterRay Y Hachem, Hiba Dagher, Anne-Marie Chaftari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2005
Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer centerHarrys A Torres, Dimitrios P Kontoyiannis, Gerald P Bodey, et al.
The Journal of Infectious Diseases|March 19, 2005
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent casesDimitrios P Kontoyiannis, Michail S Lionakis, Russell E Lewis, et al.
Medicine|September 16, 2006
Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer centerRoy F Chemaly, Shubhra Ghosh, Gerald P Bodey, et al.
Cancer|May 13, 2006
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusionsAmar Safdar, Gilhen H Rodriguez, Benjamin Lichtiger, et al.
Pageof 17